secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2026-04-09T23:59:59+00:00
Accession:  0001683168-26-002761
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals enters manufacturing supply agreement with Kenvue for Microcyn products in US
--------------------------------------------------------------------------------

- Agreement with Kenvue Brands LLC for US sale of Microcyn-based products, effective Oct 24, 2025 through March 2027.
- Term includes two optional one-year renewals upon mutual written agreement.
- Kenvue is not obligated to buy any minimum quantity; binding orders from 12-week forecast periods.
- Most-favored-customer clause requires Sonoma to extend better pricing offered to comparable CPG customers to Kenvue.
- Agreement is non-exclusive; Kenvue may manufacture or source similar products from third parties.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316826002761/0001683168-26-002761-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316826002761/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-002761

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer